Company Overview of IntegraGen, Inc.
IntegraGen, Inc. is a molecular diagnostics firm which develops and markets proprietary gene mapping technology GenomeHIP for curing multifactorial diseases such as diabetes, obesity, and autism. The company was founded in 2006 and is based in New York, New York. IntegraGen, Inc. operates as a subsidiary of IntegraGen S.A.
1251 Avenue of the Americas
New York, NY 10020
Founded in 2006
Key Executives for IntegraGen, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact IntegraGen, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.